Aesthetic Medicine Market Research, 2033
The global aesthetic medicine market size was valued at $129.0 billion in 2023 and is projected to reach $488.7 billion by 2033, growing at a CAGR of 14.3% from 2024 to 2033.
Market Introduction
The aesthetic medicine market size is rapidly expanding, offering a diverse range of procedures aimed at enhancing individuals' physical appearance through minimally invasive techniques. Also known as cosmetic medicine or appearance medicine, this field encompasses treatments ranging from facial rejuvenation to hair restoration and body contouring. It is a distinct clinical specialty that focuses on providing elective procedures for healthy adult patients seeking to address various cosmetic concerns. With a growing demand for natural-looking results, aesthetic medicine combines medical expertise with artistry, attracting professionals trained in cosmetology courses like hair transplant or other specialized training to meet the increasing needs of this thriving market.
Key Takeaways
- The aesthetic medicine market study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
- More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major aesthetic medicine industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
- The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.
Key Market Dynamics
The continuous evolution of aesthetic medicine is driven by a shift towards minimally invasive treatments with a growing emphasis on non-invasive procedures. In addition, the surge in demand for treatments like Botox and dermal fillers emphasizes a growing preference for safer, less invasive options. This trend not only reflects a desire for aesthetic improvement but also prioritizes patient safety and satisfaction. As the industry continues to evolve, these trends reinforce the move toward enhancing natural beauty while minimizing the need for invasive surgeries. These factors are anticipated to boost the aesthetic medicine market share in the coming years.
However, as aesthetic medicine evolves with new procedures and technologies, providers may lack expertise, leading to potential treatment errors and sub-optimal outcomes. In addition, safety concerns arise due to varying technology and delivery methods, posing risks such as discoloration and contraindications, especially for off-label uses. Patients must carefully consider the long-term implications and align treatments with personal aesthetic goals to mitigate the uncertainty and potential hazards associated with rapidly evolving trends in aesthetic medicine. These factors are anticipated to hamper the aesthetic medicine market growth in the coming years.
The aesthetic medicine market expansion is driven by several technological advancements. The integration of 3D imaging, virtual reality, and AI-powered skin analysis enhances patient consultations, treatment planning, and outcome visualization. These technologies improve patient satisfaction through realistic previews and personalized treatment recommendations. Emerging innovations such as augmented reality, nanotechnology, and bioprinting promise to further revolutionize the field. Clinics investing in these technologies can offer superior care, attract tech-savvy patients, and differentiate themselves in a competitive market. These factors are anticipated to boost the aesthetic medicine market forecast in the coming years.
Analysis of Global Aesthetic Medicine Market Opportunity
The International Society of Aesthetic Plastic Surgery (ISAPS) is the world’s leading professional body for board-certified aesthetic plastic surgeons, founded in 1970. The latest ISAPS survey conducted in 2022, highlighted a global rise in aesthetic surgery, with significant increase in both surgical and non-surgical procedures. Liposuction and botulinum toxin injections remain the most popular treatments, reflecting growing patient demand and technological advancements in aesthetic medicine.
Popularity of Aesthetic Surgery Worldwide, 2022 Statistics
Statistic | Data |
Overall increase in aesthetic procedures (2022) | 11.2% |
Total surgical procedures | 14.9 million |
Total non-surgical procedures | 18.8 million |
Increase in surgical procedures (last 4 years) | 41.3% |
Increase in non-surgical procedures (last 4 years) | 57.8% |
Most common surgical procedure | Liposuction (2.3 million procedures) |
Most common non-surgical procedure | Botulinum toxin (9 million procedures) |
Breast augmentation procedures (2022) | 2.2 million (29% increase from 2021) |
Buttock augmentation procedures (2022) | 820,762 (56.8% increase) |
Top countries for procedures | USA (7.4 million), Brazil (8.9%), Japan (7.3%) |
Procedures performed on women | 85.7% of total procedures |
Increase in procedures performed on men | 18% |
Market Segmentation
The aesthetic medicine market is segmented into procedure type and region. On the basis of procedure type, the market is divided into invasive procedures (breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tuck, and others) and non-invasive procedures (Botox injections, soft tissue fillers, chemical peel, laser hair removal, microdermabrasion, and others) . Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Country Market Outlook
The UK aesthetics industry has seen remarkable growth in 2023, reflecting a global trend towards increase in demand for aesthetic procedures. Currently valued at over $3.9 billion (£3.6 billion) , the UK market is a significant contributor to the global aesthetics industry. There are at least 940 aesthetic clinics in the UK, with 69% of practitioners being doctors, dentists, or nurses.
In 2022, 501, 822 aesthetic procedures were performed, with injectables like Botox being the most popular. Interest in non-invasive treatments has surged, with 7.7 million people undergoing procedures in the past year, representing 11% of the population. Furthermore, 13.9 million individuals are considering treatments within the next 12 months. The industry could be worth $5.8 billion (£5.4 billion) by 2026.
Social media and influencers have played a significant role in this growth, especially among younger demographics. Laser hair removal is the most searched aesthetic treatment in the UK, with demand highest in Greater London. Men are increasingly engaging with aesthetic treatments, primarily for self-confidence and anti-aging reasons. These factors are anticipated to boost the aesthetic medicine market growth in the UK.
Competitive Landscape
Some of the major players driving the aesthetic medicine market share include AbbVie Inc., Candela Corporation, Cynosure Aesthetics, Evolus Inc., Revance Galderma, Lumenis Be Ltd., Alma Lasers, Solta Medical, Cutera, Inc., Merz Pharma, and others.
Recent Key Strategies and Developments
- On May 14, 2024, Ascend Plastic Surgery Partners (Ascend) proudly announced the addition of Tallahassee Plastic Surgery Clinic to its elite network. This partnership, involving Dr. Larry Harper, Dr. Alfredo Paredes, and Dr. Jeffrey Rawlings, exemplifies Ascend's commitment toward innovation and excellence in aesthetic medicine. Ascend's CEO, Anthony Milonas, and Chief Medical Officer, Dr. William Hedden, highlight the alignment of shared goals and values, enhancing patient care and fostering professional growth within a collaborative community. This expansion marks a significant milestone in Ascend's mission to redefine aesthetic medicine.
- On April 25, 2024, Cartessa Aesthetics, a prominent North American aesthetic medical device company, unveiled PHYSIQ 360, a revolutionary advancement in non-invasive body contouring. Developed in collaboration with DEKA, a leading global aesthetic laser manufacturer, PHYSIQ 360 represents the next generation of body technology. This groundbreaking treatment combines laser energy and muscle stimulation to offer customizable and optimized solutions for fat reduction and muscle building.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the aesthetic medicine market analysis from 2023 to 2033 to identify the prevailing aesthetic medicine market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the aesthetic medicine market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
Apart from the points mentioned above, the report includes the analysis of the regional as well as global aesthetic medicine market trends, key players, market segments, application areas, and market growth strategies.
Aesthetic Medicine Industry Trends
- On May 02, 2024, Elevai Labs, a leading company operating in medical aesthetics, unveiled two new subsidiaries, Elevai Biosciences, Inc. and Elevai Skincare, Inc., signaling a strategic pivot towards cutting-edge aesthetic medicines and exosome skincare technologies. Elevai Biosciences will lead the development of breakthrough therapies targeting obesity-related indications, starting with EL-22 and EL-32. Elevai Skincare will drive the commercialization of exosome skincare products, focusing on the medical dispensed skincare market. With a commitment toward innovation, Elevai aims to reshape the medical aesthetics landscape, positioning itself as a leader in both aesthetic medicines and skincare solutions. This strategic move highlights Elevai's dedication to advancing the future of aesthetic medicine and skincare.
- In March 2024, Merz Aesthetics, a global leader in medical aesthetics, unveiled groundbreaking insights and product data at the 2024 Aesthetic and Anti-Aging Medicine World Congress (AMWC) . Hosting a sponsored symposium and presenting five e-posters, Merz aims to spotlight advancements in regenerative aesthetics and discuss trends shaping the industry. With a commitment toward empowering healthcare professionals and patients worldwide, Merz's innovative portfolio, including injectables and skin care treatments, highlights its dedication to enhancing confidence and well-being.
- In March 2024, Allergan Aesthetics, the leading pharmaceutical company, announced to lead an initiative, ‘Moving the Needle on Ethics, ’ aimed at fostering discussions and promoting ethical standards in aesthetics. Through a collaboration with global medical aesthetics experts, the program launches at the Anti-Age Medicine World Congress (AMWC) , unveiling a comprehensive book of interviews and articles. With the industry projected to witness exponential growth, the focus on transparency and integrity is paramount. By engaging practitioners worldwide and emphasizing ethical excellence, Allergan Aesthetics seeks to prioritize patient safety and ensure positive outcomes. This groundbreaking initiative highlights their commitment toward shaping an ethical framework for the future of aesthetics.
Key Sources Referred
- American Association of Aesthetic Medicine and Surgery (AAAMS)
- Aesthetic Medicine India Magazine
- National Laser Institute
- WorldMetrics.org
- AmSpa
Aesthetic Medicine Market Report Highlights
| Aspects | Details |
 Market Size By 2033 | USD 488.7 Billion |
 Growth Rate | CAGR of 14.3% |
 Forecast period | 2024 - 2033 |
 Report Pages | 316 |
 By Procedure Type |
|
 By Region |
|
 Key Market Players | Merz Pharma, Candela Corporation., Revance Galderma, Lumenis Be Ltd., Alma Lasers, Evolus Inc., AbbVie Inc., Cynosure Aesthetics, Solta Medical, Cutera, Inc. |
Analyst Review
The aesthetic medicine market is anticipated to witness trends towards non-invasive procedures, including laser treatments and injectables, personalized skincare solutions, digital consultations, and increased demand for natural-looking results.
The leading application of aesthetic medicine includes its role in non-invasive procedures.
North America is the largest regional market for aesthetic medicine.
The global aesthetic medicine market is estimated to reach $488.7 billion by 2033.
The top companies to hold the market share in aesthetic medicine are AbbVie Inc., Candela Corporation, Cynosure Aesthetics, Evolus Inc., Revance Galderma, Lumenis Be Ltd., Alma Lasers, Solta Medical, Cutera, Inc., and Merz Pharma.
Loading Table Of Content...
